Form 8-K - Current report:
SEC Accession No. 0001193125-21-352679
Filing Date
2021-12-09
Accepted
2021-12-09 16:15:41
Documents
15
Period of Report
2021-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d264618d8k.htm   iXBRL 8-K 36557
2 EX-10.1 d264618dex101.htm EX-10.1 929452
6 GRAPHIC g264618g1208220102417.jpg GRAPHIC 2100
7 GRAPHIC g264618g1209065442537.jpg GRAPHIC 3062
  Complete submission text file 0001193125-21-352679.txt   1314690

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20211209.xsd EX-101.SCH 2883
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20211209_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20211209_pre.xml EX-101.PRE 10947
8 EXTRACTED XBRL INSTANCE DOCUMENT d264618d8k_htm.xml XML 3325
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 211482150
SIC: 2835 In Vitro & In Vivo Diagnostic Substances